Sarissa Capital Management LP
Q3 2025 13F Holdings
- Locationgreenwich, CT
- Num holdings
8
- Value ($000)
$180,392
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001577524
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
INVA INNOVIVA INC | COM | 45781M101 | $51.39 M | 29 % | 2,816,022 | ||
NBIX NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | $42.56 M | 24 % | 303,151 | ||
CYTK CYTOKINETICS INC | COM NEW | 23282W605 | $32.34 M | 18 % | 588,357 | ||
IRWD IRONWOOD PHARMACEUTICALS INC | COM CL A | 46333X108 | $20.85 M | 12 % | 15,919,435 | ||
AMARIN CORP PLC | SPONSORED ADR | 023111404 | $20.35 M | 11 % | 1,242,527 | ||
LNTH LANTHEUS HLDGS INC | COM | 516544103 | $9.31 M | 5 % | 181,450 | ||
REGN REGENERON PHARMACEUTICALS | COM | 75886F107 | $2.36 M | 1 % | 4,190 | ||
VOR BIOPHARMA INC | COM NEW | 929033207 | $1.24 M | 1 % | 25,399 |
Rows Per Page
10
- 10
- 50
- 100